BETA-INTERFERON-1a (Rebif®)

Clinical Indication

Multiple sclerosis in adults

Comments

In line with NICE TA 527
Implementation date 27th September 2018

Date of classification

August 2018

Review date

August 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).